The Associated Press @AP
The maker of a drug intended to reduce premature births is making a last-ditch effort to keep its medication on the market, even as health regulators insist that it doesn’t work. An FDA meeting to review the drug started Monday. https://t.co/6XzWlGV4Fy — PolitiTweet.org